Literature DB >> 19572335

Quality of care in inflammatory bowel disease: a review and discussion.

Michael D Kappelman1, Lena Palmer, Brendan M Boyle, David T Rubin.   

Abstract

The Institute of Medicine's publications To Err Is Human and Crossing the Quality Chasm publicized the widespread deficits in U.S. health care quality. Emerging studies continue to reveal deficits in the quality of adult and pediatric care, including subspecialty care. The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis require diligent, long-term management and attention to their impact on intestinal and extraintestinal organ systems. Although the quality of IBD care has not been prospectively or comprehensively evaluated in the United States, several small studies have demonstrated significant variation in care. As variation may indicate underuse, overuse, or misuse of medical services, such variation suggests a clear need for translating evidence-based practices into the actual practice and follow-up provided for patients. This article reviews the history, rationale, and methods of quality measurement and improvement and identifies the unique challenges in adapting these general strategies to the care of the inflammatory bowel diseases.

Entities:  

Mesh:

Year:  2010        PMID: 19572335     DOI: 10.1002/ibd.21028

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  25 in total

1.  Framework for assessing quality of care for inflammatory bowel disease in Sweden.

Authors:  Martin Rejler; Jörgen Tholstrup; Mattias Elg; Anna Spångéus; Boel Andersson Gäre
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

2.  Advances in IBD: Current Developments in the Treatment of Inflammatory Bowel Diseases.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04

3.  Satisfaction with patient-doctor relationships in inflammatory bowel diseases: examining patient-initiated change of specialist.

Authors:  Daniel R van Langenberg; Jane M Andrews
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

4.  Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners).

Authors:  Rachel L Randell; Millie D Long; Suzanne F Cook; Christina E D Wrennall; Wenli Chen; Christopher F Martin; Kristen Anton; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

5.  State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.

Authors:  Benjamin L Cohen; Christina Ha; Ashwin N Ananthakrishnan; Florian Rieder; Meenakshi Bewtra
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

6.  Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.

Authors:  Seth D Crockett; Isaac M Lipkus; Stephanie D Bright; Richard E Sampliner; Kenneth K Wang; Vikram Boolchand; Lori S Lutzke; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2011-11-17       Impact factor: 9.427

Review 7.  Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

8.  Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey.

Authors:  Lea I Kredel; Oliver Schneidereit; Jörg C Hoffmann; Britta Siegmund; Jan C Preiß
Journal:  Int J Colorectal Dis       Date:  2018-12-07       Impact factor: 2.571

9.  Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study.

Authors:  Matthew P Kronman; Jeffrey S Gerber; Priya A Prasad; Amanda L Adler; Julie A Bass; Jason G Newland; Kavisha M Shah; Danielle M Zerr; Rui Feng; Susan E Coffin; Theoklis E Zaoutis
Journal:  J Pediatric Infect Dis Soc       Date:  2012-07-03       Impact factor: 3.164

Review 10.  Pediatric inflammatory bowel disease and depression: treatment implications.

Authors:  Divya Keethy; Christine Mrakotsky; Eva Szigethy
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.